Business Description
Scinai Immunotherapeutics Ltd
ISIN : US09073Q2049
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | -0.15 | |||||
Debt-to-Equity | -7.36 | |||||
Debt-to-EBITDA | -1.93 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 44.6 | |||||
3-Year EPS without NRI Growth Rate | 50.3 | |||||
3-Year FCF Growth Rate | 47.6 | |||||
3-Year Book Growth Rate | 66.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.96 | |||||
9-Day RSI | 53.2 | |||||
14-Day RSI | 50.51 | |||||
6-1 Month Momentum % | -27.8 | |||||
12-1 Month Momentum % | -74.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.36 | |||||
Quick Ratio | 4.36 | |||||
Cash Ratio | 4.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35 | |||||
Shareholder Yield % | 22.33 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -42.29 | |||||
ROIC % | -85.11 | |||||
ROC (Joel Greenblatt) % | -89.13 | |||||
ROCE % | -54.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.42 | |||||
EV-to-EBITDA | -1.51 | |||||
EV-to-FCF | -1.65 | |||||
Earnings Yield (Greenblatt) % | -70.42 | |||||
FCF Yield % | -458.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Scinai Immunotherapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -4.877 | ||
Beta | 2.42 | ||
Volatility % | 52.02 | ||
14-Day RSI | 50.51 | ||
14-Day ATR (€) | 0.018 | ||
20-Day SMA (€) | 0.4316 | ||
12-1 Month Momentum % | -74.92 | ||
52-Week Range (€) | 0.4 - 1.76 | ||
Shares Outstanding (Mil) | 4.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Scinai Immunotherapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Scinai Immunotherapeutics Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Scinai Immunotherapeutics Ltd Frequently Asked Questions
What is Scinai Immunotherapeutics Ltd(STU:2F50)'s stock price today?
When is next earnings date of Scinai Immunotherapeutics Ltd(STU:2F50)?
Does Scinai Immunotherapeutics Ltd(STU:2F50) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |